A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/66 (2006.01)
Patent
CA 2188030
Disclosed is a therapy for treating and for preventing periprosthetic bone loss by the administration of a bisphosphonate bone resorption inhibitor, e.g., alendronate, in patients who have an orthopedic implant device.
Thérapie de traitement et de prévention des pertes osseuses périprothétiques par administration d'un biphosphonate inhibiteur de résorption osseuse tel que l'alendronate à un patient porteur d'un implant orthopédique.
Yates Ashley J.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of bisphophonates for inhibiting bone resorption... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of bisphophonates for inhibiting bone resorption..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bisphophonates for inhibiting bone resorption... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2065545